No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor
-
Blast Crisis / surgery
-
Bone Marrow Purging
-
Bone Marrow Transplantation*
-
Clone Cells / pathology
-
Combined Modality Therapy
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Immunologic Factors / therapeutic use
-
Interferon-alpha / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
-
Leukemia, Myeloid, Chronic-Phase / surgery
-
Neoplastic Stem Cells / pathology
-
Philadelphia Chromosome
-
Remission Induction
-
Transplantation, Autologous
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Immunologic Factors
-
Interferon-alpha